CD8A and COVID-19: We observed a significantly higher expression of TIM-3 on CD4+ and CD8+ cells in all COVID-19 groups than in healthy controls; however, only a non-significant trend toward a higher expression of TIM-3 on CD4+ and CD8+ cells was observed in non-survivors compared to survivors.